On the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state-Reference-Cited by-同舟云学术

On the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state

Published:2022-03 Issue: Volume:69 Page:102990
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Tsakiridou Georgia,O'Dwyer Patrick J.^ORCID,Margaritis Antonios^ORCID,Box Karl J.,Vertzoni Maria,Kalantzi Lida,Reppas Christos

Funder

Horizon 2020 Framework Programme

National and Kapodistrian University of Athens

Horizon 2020

Publisher

Elsevier BV

Reference44 articles.

1. The CSD drug subset: the changing chemistry and crystallography of small molecule pharmaceuticals;Bryant;J. Pharmaceut. Sci.,2019

2. When poor solubility becomes an issue: from early stage to proof of concept;Stegemann;Eur. J. Pharmaceut. Sci.,2007

3. A biopharmaceutical classification-based Right-First-Time product approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept;Ku;Pharmaceut. Dev. Technol.,2012

4. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?;Brouwers;J. Pharmaceut. Sci.,2009

5. Dissolution of amorphous solid dispersions: theory and Practice;Fotaki,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus;Pharmaceutics;2025-02-10

2. Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules;AAPS PharmSciTech;2024-12-17

3. Bioequivalence prediction with small-scale biphasic dissolution and simultaneous dissolution-permeation apparatus—An aripiprazole case study;European Journal of Pharmaceutical Sciences;2024-07

4. Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary;European Journal of Pharmaceutical Sciences;2023-09

5. Butyryl chitosan: Synthesis, characterization and evaluation of the sustained release performance as tacrolimus carrier;Chemical Engineering Journal;2022-10